301263 logo

Guangdong Taienkang Pharmaceutical Co., Ltd. Stock Price

SZSE:301263 Community·CN¥12.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

301263 Share Price Performance

CN¥29.03
9.00 (44.93%)
CN¥29.03
9.00 (44.93%)
Price CN¥29.03

301263 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
0 Rewards

Guangdong Taienkang Pharmaceutical Co., Ltd. Key Details

CN¥674.5m

Revenue

CN¥331.6m

Cost of Revenue

CN¥342.9m

Gross Profit

CN¥319.6m

Other Expenses

CN¥23.3m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 28, 2026
0.055
50.83%
3.45%
21.5%
View Full Analysis

About 301263

Founded
1999
Employees
1081
CEO
Hanjie Zheng
WebsiteView website
www.tai-kang.com.cn

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as an agent for pharmaceutical products; and offers medical and sanitary materials, masks, sutures, surgical staplers, vascular clips and clip appliers, etc., as well as non-prescription drugs. The company was formerly known as Shantou Taikang Pharmaceutical Co., Ltd. and changed its name to Guangdong Taienkang Pharmaceutical Co., Ltd. in June 2006. Guangdong Taienkang Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Shantou, China.

Recent 301263 News & Updates

Recent updates

No updates